SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Alessandra Curioni

Alessandra Curioni

University of Fribourg, Fribourg

Prof. Alessandra Curioni-Fontecedro is Full Professor of Oncology at the University of Fribourg and Head of Medical Oncology at the Hôpital Fribourgeois (HFR) in Fribourg, Switzerland. She directs the Laboratory of Applied Cancer Research, where her work centers on thoracic malignancies — lung cancer and mesothelioma — with a focus on immunotherapy, mechanisms of resistance to immune checkpoint inhibitors, and the tumor microenvironment. She is President of the Lung Cancer Project Group of the Swiss Group for Clinical Cancer Research (SAKK) and coordinates the Lung Cancer Programme of the European School of Oncology (ESO). She is a frequent speaker at major international thoracic oncology congresses.

Connect

Alessandra Curioni

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates